MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection
Guardado en:
Autores principales: | Ekaterina Marakasova, Ancha Baranova |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/be6268b28f234c898787136f6a0f25ad |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection”
por: Jeffrey E. Gold, et al.
Publicado: (2021) -
Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study
por: Gupta Riya, et al.
Publicado: (2021) -
Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients
por: Jeffrey E. Gold, et al.
Publicado: (2020) -
Vaksinasi Measles, Mumps, dan Rubella (MMR) Sebagai Prophylaxis Terhadap COVID-19
por: Sajuni Widjaja
Publicado: (2020) -
Epidemiology of measles cases, vaccine effectiveness, and performance towards measles elimination in The Gambia.
por: Alieu Sowe, et al.
Publicado: (2021)